日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Real-World Safety Outcomes with Brolucizumab in Neovascular Age-Related Macular Degeneration: Findings from the IRIS® Registry

Brolucizumab治疗新生血管性年龄相关性黄斑变性的真实世界安全性结果：来自IRIS®注册研究的发现

期刊:Ophthalmology and Therapy
影响因子:3.2
doi:10.1007/s40123-024-00920-3
Zarbin, Marco A; MacCumber, Mathew W; Karcher, Helene; Adiguzel, Eser; Mayhook, Andrew; LaPrise, Andrew; Bilano, Ver L; Igwe, Franklin; Ip, Michael S; Wykoff, Charles C
发表日期：2024
文献求助 收藏

Student information use during the COVID-19 pandemic

新冠疫情期间学生信息的使用情况

期刊:Journal of Academic Librarianship
影响因子:2.3
doi:10.1016/j.acalib.2023.102696
Howard, Heather A; Bochenek, Annette; Mayhook, Zoeanna; Trowbridge, Trena; Lux, Steven
微生物学
新冠
发表日期：2023
文献求助 收藏

RETINAL VASCULITIS OR VASCULAR OCCLUSION AFTER BROLUCIZUMAB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: A Systematic Review of Real-World Evidence

布罗卢珠单抗治疗新生血管性年龄相关性黄斑变性后发生视网膜血管炎或血管阻塞：真实世界证据的系统评价

期刊:Retina-The Journal of Retinal and Vitreous Diseases
影响因子:2.1
doi:10.1097/IAE.0000000000003769
Wykoff, Charles C; Matsumoto, Hidetaka; Barakat, Mark R; Karcher, Helene; Lozama, Anthony; Mayhook, Andrew; Oshagbemi, Olorunfemi A; Zorina, Olessia; Hassan, Tarek S; Khanani, Arshad M; Heier, Jeffrey S
发表日期：2023
文献求助 收藏